Skip to main content

Sjogrens

RheumNow Podcast – I Wanna New Drug.V2 (9.24.2021)

Sep 23, 2021

Almost three years ago to the day, I did a podcast entitled, "I wanna new drug." As I go over this week's podcast, I want to say it again. I want a new drug safe enough to use during pregnancy, for PMR, for GVHD, and more. I'm going to cover these, and other topics including lupus, COVID

Read Article

CRESS – A New Composite Measure for Primary Sjögren's Syndrome

Aug 03, 2021

Randomized clinical trials in primary Sjögren's syndrome (pSS) are fraught with fault and inconclusive outcome measures, including the more recently developed EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI).  There's a new composite endpoint outcome for RCTs in pSS, called the Composite

Read Article

Potential Birth Defects with Hydroxychloroquine

Jul 13, 2021

Hydroxychloroquine (HCQ) is one of the safest meds used in rheumatology, but there is new claims data suggesting a small increase in the risk of malformations associated with first-trimester HCQ use.



While HCQ is generally considered safe in pregnancy, studies have been too few and

Read Article
Can Focus Score Predict Risk of Lymphoma in Sjogren's Patients? https://t.co/kBptqUx2XG https://t.co/8y1736Kj8T
Dr. John Cush @RheumNow( View Tweet )
Jun 22, 2021

Do B-cell targeted therapies still have a place for the treatment of Sjogren’s?

B-cells play a major role in the pathogenesis of primary Sjogren’s syndrome (pSS) through antibody-dependent and antibody-independent functions, as well as evident by progression to B-cell malignancies/lymphoma. Hence, targeting B-cell is attractive. Despite efficacy of B-cell depleting therapy

Read Article
Do B-cell targeted therapies still have a place for the treatment of Sjogren’s? https://t.co/96sv3beMvG https://t.co/oabgmkAfGk
Dr. John Cush @RheumNow( View Tweet )
Jun 13, 2021
Can the Focus Score predict Lymphoma in Sjogren’s syndrome? by Dr. Eric Dein ( @ejdein1 ) https://t.co/B5HN6ju3ru https://t.co/3MuXH66YqJ
Dr. John Cush @RheumNow( View Tweet )
Jun 09, 2021

Can the Focus Score predict Lymphoma in Sjogren’s syndrome?

Jun 08, 2021

Patients with Sjogren’s syndrome are nearly 19 times more likely to develop lymphoma, so identifying factors that impact this risk development is a major goal in caring for this disorder. Many risk factors are established such as low C4, palpable purpura, parotid gland enlargement, and

Read Article
Do B-cell targeted therapies still have a place for the treatment of Sjogren’s? #EULAR2021 https://t.co/96sv3beMvG https://t.co/EWKCA1KGsC
Dr. John Cush @RheumNow( View Tweet )
Jun 08, 2021
#EULAR2021 POS0230: TNFi changes intestinal microbiota in IBD-SpA ⬇️ Proteobacteria ⬆️Lachnospiraceae, Coprococcus Does inflammatory changes by TNFi restore intestinal eubiosis and does this affect SpA outcomes? @Rheumnow

Eric Dein @ejdein1( View Tweet )

Jun 05, 2021
Talk about unmet need. We must get better Rx for #Sogren’s Syndrome! Large survey show quality of life v poor in SS & correlates with degree of dryness in lacrimal & salivary glands POS0102 #EULAR2021 @eular_org @RheumNow

Janet Pope @Janetbirdope( View Tweet )

Jun 04, 2021
If we want drugs to be effective in #Sjogren’s Syndrome we need to see activity. The #Eular SS disease activity index ~ESSDAI in 511 SS pts found >50% w moderate to severe values BUT how much is Reversible ie fibro, fatigue, scarred glands? POS0105 @RheumNow @eular_org #EULAR2021

Janet Pope @Janetbirdope( View Tweet )

Jun 04, 2021
Does anti-CD20 mAb still have a place in #Sjogren? Dr Pontarini analysed salivary gland biopsy from TRACTISS and reported beneficial effects of RTX in⬇️regulating genes involved in immune cell recruitment, activation and organisation in ectopic GC #EULAR2021 #OP0136 @RheumNow https://t.co/FRUvo4JxTx
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
Jun 03, 2021
Sjogren’s QoL reported dryness correlates with objective salivary flow ⭐️lower perceived dryness associated with higher immunologic activity Abs#POS0102 #EULAR2021 @RheumNow

Robert B Chao, MD @doctorRBC( View Tweet )

Jun 03, 2021

Sinusitis Activity Linked to Brain Dysfunction

Apr 13, 2021

Have you wondered why fibromyalgia, fatigue or cognitive dysfunction often co-associate with chronic sinusitis?



A case-control study of 22 patients with chronic rhinosinusitis published in JAMA Otolaryngology–Head and Neck Surgery found that sinonasal inflammation was

Read Article

Answering questions on how COVID-19 affects rheumatic patients

Nov 10, 2020

As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives.

Read Article
Don’t forget to check the eyes. Dr Kolfenbach. Top secret and Pearls #ACR20 @RheumNow It’s also useful for dx #sjogren #sarcoidodis #Ig G4 https://t.co/dxmwuwrPqz
Nov 08, 2020
Myths surrounding #sjogren. Complications of severe dry eye. Dr Akpek #ACR20 @RheumNow https://t.co/gnZJfcpsGn
Nov 08, 2020
Living with #Sjogren #syndrome. Tips for dry mouth management. Dr Papas #ACR20 @RheumNow @ramos_casals https://t.co/uw4NH3yhpn
Nov 08, 2020
#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
Nov 08, 2020
Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are near of first therapeutic recommendations of elderly #sjogren syndrome @ramos_casals @p_brito_zeron https://t.co/yjGrSTWV1K
Nov 07, 2020
Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial https://t.co/cunDxVl5XG https://t.co/OGItXCuWDI
The Lancet Rheumatology @TheLancetRheum( View Tweet )
Nov 07, 2020
Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR
CreakyJoints.org @CreakyJoints( View Tweet )
Nov 06, 2020
Hand OA Rx strikes out. HCQ Rx neg and colchicine Trial negative. I wouldn’t put hand OA as same category of no Rx as for SSc and Sjogrens but agree though nuts to crack @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/QRe3UpKpbz

Janet Pope @Janetbirdope( View Tweet )

Jun 07, 2020
#EULAR2020 OP0096 Dr. L Chatzis study on Sjogren: 1. 2nd most common autoimm dz in women 2. women:men ratio 20:1 (not 9:1) 3. 2 types Ro-Ab: nuc. Ro60 (assc w/La)and cytopls. Ro52 (assc w/ILD/myositis) 4. Seroneg. Sjogren's (neg Ro/La/RF) good prognosis:⬇️lymphoma @RheumNow https://t.co/fV3ltQqnkf
Jun 06, 2020
×